News
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth
Alcoa Schedules First Quarter 2022 Earnings Release and Conference Call
Alcoa Corporation plans to announce its first quarter 2022 financial results on Wednesday, April 20, 2022 after the close of trading on the New York Stock Exchange.
The press release with
Fluor Joint Venture Receives Final Notice-to-Proceed on Interstate 35E Phase 2 Project in Dallas
Fluor Corporation (NYSE: FLR) announced today that Lone Star Constructors, its joint venture with Austin Bridge & Road, has been granted final notice-to-proceed by the Texas Department of
UDR Announces Public Offering of 7,000,000 Shares of Common Stock
UDR, Inc. (the “Company”) (NYSE: UDR), announced today that it is commencing an underwritten public offering of 7,000,000 shares of common stock in connection with the forward sale agreements
![Walmart Announces 2022 Annual Shareholders’ Meeting Datehttp://upload.wikimedia.org/wikipedia/commons/3/3d/Wal-Mart_logo.svg: By Wal-Mart Stores, Inc. [Public domain], via Wikimedia Commons](https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbXdCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--9fabff923f87413218748d39eadfa47a8522e488/New_Walmart_Logo.svg?locale=us){kind=logo}
Walmart Announces 2022 Annual Shareholders’ Meeting Date
Walmart Inc. (NYSE: WMT) today announced that its Annual Shareholders’ Meeting will be held on Wednesday, June 1, 2022. The meeting will be held in a virtual-only format and will begin at 10:30
ABIONYX Pharma Receives FDA Orphan Drug Designation (ODD) for CER-001 for the Treatment of LCAT Deficiency Presenting as Kidney Dysfunction and/or Ophthalmologic Disease
Regulatory News:
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for
AIG Announces Proposed Senior Notes Offering by Corebridge Financial, Inc.
American International Group, Inc. (NYSE: AIG) today announced that its majority-owned subsidiary, Corebridge Financial, Inc., intends to offer senior unsecured notes (the “Notes”) in connection
Keysight Selected by VTT to Support Open Testing and Integration Facility in Finland
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
DGAP-News: ENCAVIS AG shows significant growth in fiscal 2021 and forecasts an ongoing strong growth for 2022e
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use of their COVID-19 vaccine to include a second
2022 Annual General Meeting: shareholders approve all proposals
Hancock Whitney Corporation to Announce First Quarter 2022 Financial Results and Host Conference Call April 19
Hancock Whitney Corporation (Nasdaq: HWC) will announce first quarter 2022 financial results on Tuesday, April 19, 2022 after the market closes. Management will host a conference call for analysts
Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, continued its $5.5 million investment in six communities across the United States to improve greater
Itron and Emerson Collaborate to Offer Smart Thermostats for Demand Response Programs
Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, is collaborating with Emerson, a global technology and engineering leader, to offer reliable
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II
Guidewire Announces Latest Group of PartnerConnect Consulting Program Specialization Recipients
Guidewire (NYSE: GWRE) announced that specializations have been awarded to two Guidewire PartnerConnect Consulting partners for the Americas (AMER) and Europe (EMEA).
The PartnerConnect Consultin
Citrix® Leads Way in Delivering Secure Hybrid Work
The world is rapidly moving to hybrid work. And Citrix Systems, Inc. (NASDAQ: CTXS) is a recognized frontrunner in delivering all the technologies required to enable it.
“As companies transition
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200, a wholly-owned
Tokens.com Launches Canada SailGP Team Metaverse Headquarters
Tokens.com Corp. (NEO Exchange Canada: COIN) (Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or “the Company”), a publicly-traded company that invests in Web3 crypto assets and
Xebec Presents Three-Year Strategic Plan to Power Its Growth in Sustainable Gases
Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of sustainable gas technologies, is pleased to announce today its three-year strategic plan to power its growth in sustainable gases
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential
Pfizer Inc. (NYSE: PFE) today announced positive top-line results from a second Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor
Leading Northern Ireland Convenience Retailer The Henderson Group Selects GLORY CASHINFINITYTM Solutions As Key Enabler for Store Transformation Programme
Glory (TYO: 6457), a global leader in retail cash automation solutions today announced that major Northern Ireland retailer The Henderson Group, has signed a significant new order with the company
Recordati Rare Diseases Announce Publication in the Journal of Clinical Endocrinology & Metabolism of the Phase III LINC 4 Study Confirming the Efficacy and Safety of Isturisa® (Osilodrostat) in Patients With Cushing’s Disease
Recordati Rare Diseases announce today the publication of positive results from the Phase III LINC 4 study of Isturisa in The Journal of Clinical Endocrinology & Metabolism.1 These data reinforce